| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF3489-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB3488-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF3488-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-73338 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF5460-SP | |||
![Western Blot: Peroxiredoxin 2 Antibody (4E10-2D2) [H00007001-M01] - PRDX2 monoclonal antibody (M01), clone 4E10-2D2 Analysis of PRDX2 expression in Hela.](http://images.novusbio.com/fullsize/Peroxiredoxin-2-Antibody-4E10-2D2-Western-Blot-H00007001-M01-img0011.jpg "Western Blot: Peroxiredoxin 2 Antibody (4E10-2D2) [H00007001-M01] - PRDX2 monoclonal antibody (M01), clone 4E10-2D2 Analysis of PRDX2 expression in Hela.")
![Immunocytochemistry/Immunofluorescence: Peroxiredoxin 2 Antibody (4E10-2D2) [H00007001-M01] - Analysis of monoclonal antibody to PRDX2 on HeLa cell. Antibody concentration 10 ug/ml.](http://images.novusbio.com/fullsize/Peroxiredoxin-2-Antibody-4E10-2D2-Immunocytochemistry-Immunofluorescence-H00007001-M01-img0007.jpg)
![Immunohistochemistry-Paraffin: Peroxiredoxin 2 Antibody (4E10-2D2) [H00007001-M01] - Analysis of monoclonal antibody to PRDX2 on formalin-fixed paraffin-embedded human malignant lymphoma, diffuse large B tissue. Antibody concentration 1 ug/ml.](http://images.novusbio.com/fullsize/Peroxiredoxin-2-Antibody-4E10-2D2-Immunohistochemistry-Paraffin-H00007001-M01-img0009.jpg)
![Western Blot: Peroxiredoxin 2 Antibody (4E10-2D2) [H00007001-M01] - Analysis of PRDX2 expression in transfected 293T cell line by PRDX2 monoclonal antibody (M01), clone 4E10-2D2.Lane 1: PRDX2 transfected lysate(21.9 KDa).Lane 2: Non-transfected lysate.](http://images.novusbio.com/fullsize/Peroxiredoxin-2-Antibody-4E10-2D2-Western-Blot-H00007001-M01-img0012.jpg)
![ELISA: Peroxiredoxin 2 Antibody (4E1.0-2D2) [H00007001-M01] - Peroxiredoxin 2 Antibody (4E10-2D2) [H00007001-M01] - Detection limit for recombinant GST tagged PRDX2 is approximately 1ng/ml as a capture antibody.](http://images.novusbio.com/fullsize/Peroxiredoxin-2-Antibody-4E1-0-2D2-ELISA-H00007001-M01-img0013.jpg)
![<b>Biological Strategies Validation and Genetic Strategies Validation.</b>Knockdown Validated: Peroxiredoxin 2 Antibody (4E10-2D2) [H00007001-M01] - PRDX2 knockdown increases PRDX4 protein levels in HeLa cells. HeLa subclones were exposed to 20% or 1% O2 for indicated time. Each WCL was subject to immunoblot assays with the indicated antibodies (PRDX2 H00007001-M01 and PRDX4 NBP1-31435). Image collected and cropped by CiteAb from the following publication (oncotarget.com/abstract/7142), licensed under a CC-BY license.](http://images.novusbio.com/fullsize/Peroxiredoxin-2-Antibody-4E10-2D2-Knockdown-Validated-H00007001-M01-img0014.jpg)
![Western Blot: Peroxiredoxin 2 Antibody (4E10-2D2) [H00007001-M01] - Expression of PRDX2 or PRDX4 does not affect HIF-1 alpha or HIF-2 alpha protein levelsA. & B. HeLa cells were transfected with EV or vector encoding PRDX2-V5 (A, P2) or PRDX4-V5 (B, P4), & exposed to 20% or 1% O2 for 24 h. WCL was subject to immunoblot assays with antibody against HIF-1 alpha , HIF-2 alpha , V5, or acin. C. HeLa-shSC (sc) & HeLa-shPRDX(2+4) (2+4) cells were exposed to 20% or 1% O2 for 24 h in the presence of doxycycline. WCL was subject to immunoblot assays with antibodies against HIF-1 alpha , HIF-2 alpha , PRDX2, PRDX4, & actin. Image collected & cropped by CiteAb from the following publication (//www.oncotarget.com/lookup/doi/10.18632/oncotarget.7142), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/h00007001-m01_mouse-monoclonal-peroxiredoxin-2-antibody-4e10-2d2-31020241534360.jpg)
![Western Blot: Peroxiredoxin 2 Antibody (4E10-2D2) [H00007001-M01] - PRDX2 knockdown increases PRDX4 protein levels in HeLa cellsHeLa subclones were exposed to 20% or 1% O2 for indicated time. Each WCL was subject to immunoblot assays with the indicated antibodies. SC, scrambled control shRNA. P2, PRDX2 shRNA. Image collected & cropped by CiteAb from the following publication (//www.oncotarget.com/lookup/doi/10.18632/oncotarget.7142), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/h00007001-m01_mouse-monoclonal-peroxiredoxin-2-antibody-4e10-2d2-310202415304247.jpg)
![Western Blot: Peroxiredoxin 2 Antibody (4E10-2D2) [H00007001-M01] - Hypoxia induces the nuclear translocation of PRDX2 & PRDX4HeLa cells were transfected with vector encoding PRDX2-V5 (P2) or PRDX4-V5 (P4), or empty vector (EV), & exposed to 20% or 1% O2 for 48 h. Nuclear & cytosolic fractions were isolated & subject to immunoblot assays with antibodies against HIF-1 alpha , HIF-2 alpha , V5, alpha -tubulin, & histone H3. Image collected & cropped by CiteAb from the following publication (//www.oncotarget.com/lookup/doi/10.18632/oncotarget.7142), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/h00007001-m01_mouse-monoclonal-peroxiredoxin-2-antibody-4e10-2d2-310202415304252.jpg)
![Western Blot: Peroxiredoxin 2 Antibody (4E10-2D2) [H00007001-M01] - Mapping the PRDX2 & PRDX4 binding domains of HIF-1 alpha A. & B. HeLa cells were transfected with PRDX2-V5 (A) or PRDX4-V5 (B) vector & WCL was incubated with purified GST or GST-HIF-1 alpha fusion protein in the presence of glutathione-Sepharose beads, followed by immunoblot assays with anti-V5 antibody (upper panels) or Ponceau S staining (lower panels). Image collected & cropped by CiteAb from the following publication (//www.oncotarget.com/lookup/doi/10.18632/oncotarget.7142), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/h00007001-m01_mouse-monoclonal-peroxiredoxin-2-antibody-4e10-2d2-31020241534389.jpg)
![Western Blot: Peroxiredoxin 2 Antibody (4E10-2D2) [H00007001-M01] - Expression of PRDX2 or PRDX4 does not affect HIF-1 alpha or HIF-2 alpha protein levelsA. & B. HeLa cells were transfected with EV or vector encoding PRDX2-V5 (A, P2) or PRDX4-V5 (B, P4), & exposed to 20% or 1% O2 for 24 h. WCL was subject to immunoblot assays with antibody against HIF-1 alpha , HIF-2 alpha , V5, or acin. C. HeLa-shSC (sc) & HeLa-shPRDX(2+4) (2+4) cells were exposed to 20% or 1% O2 for 24 h in the presence of doxycycline. WCL was subject to immunoblot assays with antibodies against HIF-1 alpha , HIF-2 alpha , PRDX2, PRDX4, & actin. Image collected & cropped by CiteAb from the following publication (//www.oncotarget.com/lookup/doi/10.18632/oncotarget.7142), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/h00007001-m01_mouse-monoclonal-peroxiredoxin-2-antibody-4e10-2d2-310202415175220.jpg)
![Western Blot: Peroxiredoxin 2 Antibody (4E10-2D2) [H00007001-M01] - Effect of PRDX2 & PRDX4 on HIF-1 alpha -p300 interactionHeLa cells were transfected with empty vector (EV) or vector encoding PRDX2-V5 or PRDX4-V5, & exposed to 1% O2 for 24 h. WCL was subject to IP with anti-p300 antibody, followed by immunoblot assays using antibodies against HIF-1 alpha , V5, & p300. Image collected & cropped by CiteAb from the following publication (//www.oncotarget.com/lookup/doi/10.18632/oncotarget.7142), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/h00007001-m01_mouse-monoclonal-peroxiredoxin-2-antibody-4e10-2d2-310202415392540.jpg)
![Western Blot: Peroxiredoxin 2 Antibody (4E10-2D2) [H00007001-M01] - PRDX2 expression is regulated by HIF-1 & HIF-2A. HeLa cells were exposed to 20% or 1% O2 for 24 h. RT-qPCR assays were performed using primers specific for the indicated mRNAs. Data are shown as mean ± SEM, n = 3. ***p < 0.001 versus 20% O2. B. HeLa cells were exposed to 20% or 1% O2 for the indicated time. WCLs were subject to immunoblot assays with antibodies against PRDX2, HIF-1 alpha , HIF-2 alpha , & actin. The PRDX2 & actin bands were quantified by densitometry & normalized to 0 h (20% O2). Normalized data are shown as mean ± SEM, n = 3. *p < 0.05, ***p < 0.001 versus 20% O2. C. HeLa-shSC (SC), HeLa-shHIF-1 alpha (1 alpha ), HeLa-shHIF-2 alpha (2 alpha ), & HeLa-sh1 alpha +2 alpha (DKD) cells were exposed to 20% or 1% O2 for 72 h. WCLs were subject to immunoblot assays with antibodies against PRDX2, HIF-1 alpha , HIF-2 alpha , & actin. Image collected & cropped by CiteAb from the following publication (//www.oncotarget.com/lookup/doi/10.18632/oncotarget.7142), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/h00007001-m01_mouse-monoclonal-peroxiredoxin-2-antibody-4e10-2d2-310202415482276.jpg)
![Western Blot: Peroxiredoxin 2 Antibody (4E10-2D2) [H00007001-M01] - PRDX proteins bind to HIF-1 alpha & HIF-2 alpha A. HeLa cells were transfected with an expression vector encoding V5-epitope-tagged PRDX2 (PRDX2-V5) & exposed to 1% O2 for 24 h. Whole cell lysate (WCL) was subject to immunoprecipitation (IP) using anti-HIF-1 alpha antibody or control IgG, followed by immunoblot assays with antibody against V5 epitope or HIF-1 alpha . B. HeLa cells were transfected with PRDX2-V5 vector & exposed to 1% O2 for 24 h. The WCL was subject to IP using anti-V5 antibody or control IgG, followed by immunoblot assays with antibody against V5 or HIF-1 alpha . Light IgG: immunoglobulin light chain from the secondary antibody. C. HeLa cells were transfected with vector encoding a V5-tagged PRDX family member & exposed to 1% O2 for 24 h. WCL was subject to IP using anti-HIF-1 alpha antibody, followed by immunoblot assays with antibody against V5 or HIF-1 alpha . D. HeLa cells were transfected with empty vector (EV) or vector encoding a V5-tagged PRDX family member & exposed to 1% O2 for 24 h. WCL was subject to IP using anti-HIF-2 alpha antibody, followed by immunoblot assays with antibody against V5 or HIF-2 alpha . Image collected & cropped by CiteAb from the following publication (//www.oncotarget.com/lookup/doi/10.18632/oncotarget.7142), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/h00007001-m01_mouse-monoclonal-peroxiredoxin-2-antibody-4e10-2d2-310202415482298.jpg)
![Western Blot: Peroxiredoxin 2 Antibody (4E10-2D2) [H00007001-M01] - PRDX proteins bind to HIF-1 alpha & HIF-2 alpha A. HeLa cells were transfected with an expression vector encoding V5-epitope-tagged PRDX2 (PRDX2-V5) & exposed to 1% O2 for 24 h. Whole cell lysate (WCL) was subject to immunoprecipitation (IP) using anti-HIF-1 alpha antibody or control IgG, followed by immunoblot assays with antibody against V5 epitope or HIF-1 alpha . B. HeLa cells were transfected with PRDX2-V5 vector & exposed to 1% O2 for 24 h. The WCL was subject to IP using anti-V5 antibody or control IgG, followed by immunoblot assays with antibody against V5 or HIF-1 alpha . Light IgG: immunoglobulin light chain from the secondary antibody. C. HeLa cells were transfected with vector encoding a V5-tagged PRDX family member & exposed to 1% O2 for 24 h. WCL was subject to IP using anti-HIF-1 alpha antibody, followed by immunoblot assays with antibody against V5 or HIF-1 alpha . D. HeLa cells were transfected with empty vector (EV) or vector encoding a V5-tagged PRDX family member & exposed to 1% O2 for 24 h. WCL was subject to IP using anti-HIF-2 alpha antibody, followed by immunoblot assays with antibody against V5 or HIF-2 alpha . Image collected & cropped by CiteAb from the following publication (//www.oncotarget.com/lookup/doi/10.18632/oncotarget.7142), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/h00007001-m01_mouse-monoclonal-peroxiredoxin-2-antibody-4e10-2d2-310202415485134.jpg)
![Western Blot: Peroxiredoxin 2 Antibody (4E10-2D2) [H00007001-M01] - PRDX2 expression is regulated by HIF-1 & HIF-2A. HeLa cells were exposed to 20% or 1% O2 for 24 h. RT-qPCR assays were performed using primers specific for the indicated mRNAs. Data are shown as mean ± SEM, n = 3. ***p < 0.001 versus 20% O2. B. HeLa cells were exposed to 20% or 1% O2 for the indicated time. WCLs were subject to immunoblot assays with antibodies against PRDX2, HIF-1 alpha , HIF-2 alpha , & actin. The PRDX2 & actin bands were quantified by densitometry & normalized to 0 h (20% O2). Normalized data are shown as mean ± SEM, n = 3. *p < 0.05, ***p < 0.001 versus 20% O2. C. HeLa-shSC (SC), HeLa-shHIF-1 alpha (1 alpha ), HeLa-shHIF-2 alpha (2 alpha ), & HeLa-sh1 alpha +2 alpha (DKD) cells were exposed to 20% or 1% O2 for 72 h. WCLs were subject to immunoblot assays with antibodies against PRDX2, HIF-1 alpha , HIF-2 alpha , & actin. Image collected & cropped by CiteAb from the following publication (//www.oncotarget.com/lookup/doi/10.18632/oncotarget.7142), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/h00007001-m01_mouse-monoclonal-peroxiredoxin-2-antibody-4e10-2d2-31020241548364.jpg)
![Western Blot: Peroxiredoxin 1 Antibody [NBP1-82558] - Analysis in human cell lines PC-3 and SK-MEL-30 using Anti-PRDX1 antibody. Corresponding PRDX1 RNA-seq data are presented for the same cell lines. Loading control: Anti-GAPDH.](http://images.novusbio.com/fullsize/Peroxiredoxin-1-Antibody-Western-Blot-NBP1-82558-img0008.jpg "<b>Orthogonal Strategies Validation. </b>Western Blot: Peroxiredoxin 1 Antibody [NBP1-82558] - Analysis in human cell lines PC-3 and SK-MEL-30 using Anti-PRDX1 antibody. Corresponding PRDX1 RNA-seq data are presented for the same cell lines. Loading control: Anti-GAPDH.")
![<b>Orthogonal Strategies Validation. </b>Immunocytochemistry/Immunofluorescence: Peroxiredoxin 1 Antibody [NBP1-82558] - Staining of human cell line U-2 OS shows localization to mitochondria. Antibody staining is shown in green.](http://images.novusbio.com/fullsize/Peroxiredoxin-1-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-82558-img0007.jpg)
![Immunohistochemistry-Paraffin: Peroxiredoxin 1 Antibody [NBP1-82558] - Staining of human tonsil shows moderate to strong cytoplasmic positivity in non-germinal center cells.](http://images.novusbio.com/fullsize/Peroxiredoxin-1-Antibody-Immunohistochemistry-Paraffin-NBP1-82558-img0014.jpg)
![Immunohistochemistry-Paraffin: Peroxiredoxin 1 Antibody [NBP1-82558] - Staining of human breast cancer shows strong cytoplasmic positivity in tumor cells.](http://images.novusbio.com/fullsize/Peroxiredoxin-1-Antibody-Immunohistochemistry-Paraffin-NBP1-82558-img0011.jpg)
![Immunohistochemistry-Paraffin: Peroxiredoxin 1 Antibody [NBP1-82558] - Staining of human liver shows moderate cytoplasmic positivity in hepatocytes.](http://images.novusbio.com/fullsize/Peroxiredoxin-1-Antibody-Immunohistochemistry-Paraffin-NBP1-82558-img0012.jpg)
![Immunohistochemistry-Paraffin: Peroxiredoxin 1 Antibody [NBP1-82558] - Staining of human skeletal muscle shows no positivity in myocytes as expected.](http://images.novusbio.com/fullsize/Peroxiredoxin-1-Antibody-Immunohistochemistry-Paraffin-NBP1-82558-img0013.jpg)
![Western Blot: Peroxiredoxin 6 Antibody (3A10-2A11) [H00009588-M01] - PRDX6 monoclonal antibody (M01), clone S1. Analysis of PRDX6 expression in MCF-7.](http://images.novusbio.com/fullsize/Peroxiredoxin-6-Antibody-3A10-2A11-Western-Blot-H00009588-M01-img0002.jpg "Western Blot: Peroxiredoxin 6 Antibody (3A10-2A11) [H00009588-M01] - PRDX6 monoclonal antibody (M01), clone S1. Analysis of PRDX6 expression in MCF-7.")
![Western Blot: Peroxiredoxin 6 Antibody (3A10-2A11) [H00009588-M01] - PRDX6 monoclonal antibody (M01), clone 3A10-2A11. Analysis of PRDX6 expression in human liver.](http://images.novusbio.com/fullsize/Peroxiredoxin-6-Antibody-3A10-2A11-Western-Blot-H00009588-M01-img0003.jpg)
![ELISA: Peroxiredoxin 6 Antibody (3A10-2A11) [H00009588-M01] - Detection limit for recombinant GST tagged PRDX6 is 3 ng/ml as a capture antibody.](http://images.novusbio.com/fullsize/Peroxiredoxin-6-Antibody-3A10-2A11-Sandwich-ELISA-H00009588-M01-img0001.jpg)
![Western Blot: Peroxiredoxin-6 Antibody [NBP2-19779] - Sample (50 ug of whole cell lysate) A: Mouse Brain, 12% SDS PAGE gel, diluted at 1:1000.](http://images.novusbio.com/fullsize/Peroxiredoxin-6-Antibody-Western-Blot-NBP2-19779-img0002.jpg "Western Blot: Peroxiredoxin-6 Antibody [NBP2-19779] - Sample (50 ug of whole cell lysate) A: Mouse Brain, 12% SDS PAGE gel, diluted at 1:1000.")
![Immunocytochemistry/Immunofluorescence: Peroxiredoxin-6 Antibody [NBP2-19779] - Confocal immunofluorescence analysis of methanol-fixed HeLa, using Peroxiredoxin 6 antibody (Green) at 1:500 dilution. Alpha-tubulin filaments are labeled with Alpha-tubulin antibody (Red) at 1:2000.](http://images.novusbio.com/fullsize/Peroxiredoxin-6-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-19779-img0003.jpg)
![Western Blot: Peroxiredoxin-6 Antibody [NBP2-19779] - Sample (30 ug of whole cell lysate) A: HCT116 12% SDS PAGE gel, diluted at 1:1000.](http://images.novusbio.com/fullsize/Peroxiredoxin-6-Antibody-Western-Blot-NBP2-19779-img0001.jpg)
![Western Blot: Peroxiredoxin 4 Antibody (9A3) [NBP2-02117] - EK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY Peroxiredoxin-4 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-Peroxiredoxin-4.](http://images.novusbio.com/fullsize/Peroxiredoxin-4-Antibody-9A3-Western-Blot-NBP2-02117-img0018.jpg "Western Blot: Peroxiredoxin 4 Antibody (9A3) [NBP2-02117] - EK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY Peroxiredoxin-4 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-Peroxiredoxin-4.")
![Immunocytochemistry/Immunofluorescence: Peroxiredoxin 4 Antibody (OTI9A3) [NBP2-02117] - Staining of COS7 cells transiently transfected by pCMV6-ENTRY Peroxiredoxin-4.](http://images.novusbio.com/fullsize/Peroxiredoxin-4-Antibody-9A3-Immunocytochemistry-Immunofluorescence-NBP2-02117-img0010.jpg)
![Immunohistochemistry-Paraffin: Peroxiredoxin 4 Antibody (9A3) [NBP2-02117] - Staining of paraffin-embedded Human prostate tissue using anti-Peroxiredoxin-4 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/Peroxiredoxin-4-Antibody-9A3-Immunohistochemistry-Paraffin-NBP2-02117-img0017.jpg)
![Immunohistochemistry-Paraffin: Peroxiredoxin 4 Antibody (9A3) [NBP2-02117] - Staining of paraffin-embedded Carcinoma of Human bladder tissue using anti-Peroxiredoxin-4 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/Peroxiredoxin-4-Antibody-9A3-Immunohistochemistry-Paraffin-NBP2-02117-img0011.jpg)
![Immunohistochemistry-Paraffin: Peroxiredoxin 4 Antibody (9A3) [NBP2-02117] - Staining of paraffin-embedded Human breast tissue using anti-Peroxiredoxin-4 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/Peroxiredoxin-4-Antibody-9A3-Immunohistochemistry-Paraffin-NBP2-02117-img0012.jpg)
![Immunohistochemistry-Paraffin: Peroxiredoxin 4 Antibody (9A3) [NBP2-02117] - Staining of paraffin-embedded Human colon tissue using anti-Peroxiredoxin-4 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/Peroxiredoxin-4-Antibody-9A3-Immunohistochemistry-Paraffin-NBP2-02117-img0013.jpg)
![Immunohistochemistry-Paraffin: Peroxiredoxin 4 Antibody (9A3) [NBP2-02117] - Staining of paraffin-embedded Human endometrium tissue using anti-Peroxiredoxin-4 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/Peroxiredoxin-4-Antibody-9A3-Immunohistochemistry-Paraffin-NBP2-02117-img0014.jpg)
![Immunohistochemistry-Paraffin: Peroxiredoxin 4 Antibody (9A3) [NBP2-02117] - Staining of paraffin-embedded Human Ovary tissue using anti-Peroxiredoxin-4 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/Peroxiredoxin-4-Antibody-9A3-Immunohistochemistry-Paraffin-NBP2-02117-img0015.jpg)
![Immunohistochemistry-Paraffin: Peroxiredoxin 4 Antibody (9A3) [NBP2-02117] - Staining of paraffin-embedded Human pancreas tissue using anti-Peroxiredoxin-4 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/Peroxiredoxin-4-Antibody-9A3-Immunohistochemistry-Paraffin-NBP2-02117-img0016.jpg)
![Western Blot: Peroxiredoxin 4 Antibody (OTI9A3) - Azide and BSA Free [NBP2-73338] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY Peroxiredoxin-4 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-Peroxi](http://images.novusbio.com/fullsize/Peroxiredoxin-4-Antibody-OTI9A3-Azide-and-BSA-Free-Western-Blot-NBP2-73338-img0001.jpg "Western Blot: Peroxiredoxin 4 Antibody (OTI9A3) - Azide and BSA Free [NBP2-73338] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY Peroxiredoxin-4 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-Peroxi")
![Immunocytochemistry/Immunofluorescence: Peroxiredoxin 4 Antibody (OTI9A3) - Azide and BSA Free [NBP2-73338] - Staining of COS7 cells transiently transfected by pCMV6-ENTRY Peroxiredoxin-4.](http://images.novusbio.com/fullsize/Peroxiredoxin-4-Antibody-OTI9A3-Azide-and-BSA-Free-Immunocytochemistry-Immunofluorescence-NBP2-73338-img0002.jpg)
![Immunohistochemistry: Peroxiredoxin 4 Antibody (OTI9A3) - Azide and BSA Free [NBP2-73338] - Staining of paraffin-embedded Human pancreas tissue using anti-Peroxiredoxin-4 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/Peroxiredoxin-4-Antibody-OTI9A3-Azide-and-BSA-Free-Immunohistochemistry-NBP2-73338-img0008.jpg)
![Immunohistochemistry: Peroxiredoxin 4 Antibody (OTI9A3) - Azide and BSA Free [NBP2-73338] - Staining of paraffin-embedded Carcinoma of Human bladder tissue using anti-Peroxiredoxin-4 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/Peroxiredoxin-4-Antibody-OTI9A3-Azide-and-BSA-Free-Immunohistochemistry-NBP2-73338-img0003.jpg)
![Immunohistochemistry: Peroxiredoxin 4 Antibody (OTI9A3) - Azide and BSA Free [NBP2-73338] - Staining of paraffin-embedded Human breast tissue using anti-Peroxiredoxin-4 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/Peroxiredoxin-4-Antibody-OTI9A3-Azide-and-BSA-Free-Immunohistochemistry-NBP2-73338-img0004.jpg)
![Immunohistochemistry: Peroxiredoxin 4 Antibody (OTI9A3) - Azide and BSA Free [NBP2-73338] - Staining of paraffin-embedded Human colon tissue using anti-Peroxiredoxin-4 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/Peroxiredoxin-4-Antibody-OTI9A3-Azide-and-BSA-Free-Immunohistochemistry-NBP2-73338-img0005.jpg)
![Immunohistochemistry: Peroxiredoxin 4 Antibody (OTI9A3) - Azide and BSA Free [NBP2-73338] - Staining of paraffin-embedded Human endometrium tissue using anti-Peroxiredoxin-4 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/Peroxiredoxin-4-Antibody-OTI9A3-Azide-and-BSA-Free-Immunohistochemistry-NBP2-73338-img0006.jpg)
![Immunohistochemistry: Peroxiredoxin 4 Antibody (OTI9A3) - Azide and BSA Free [NBP2-73338] - Staining of paraffin-embedded Human Ovary tissue using anti-Peroxiredoxin-4 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/Peroxiredoxin-4-Antibody-OTI9A3-Azide-and-BSA-Free-Immunohistochemistry-NBP2-73338-img0007.jpg)
![Immunohistochemistry: Peroxiredoxin 4 Antibody (OTI9A3) - Azide and BSA Free [NBP2-73338] - Staining of paraffin-embedded Human prostate tissue using anti-Peroxiredoxin-4 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/Peroxiredoxin-4-Antibody-OTI9A3-Azide-and-BSA-Free-Immunohistochemistry-NBP2-73338-img0009.jpg)
![Western Blot: Peroxiredoxin 4 Antibody [NBP2-19778] - PRDX2 knockdown increases PRDX4 protein levels in HeLa cellsHeLa subclones were exposed to 20% or 1% O2 for indicated time. Each WCL was subject to immunoblot assays with the indicated antibodies. Image collected and cropped by CiteAb from the following publication (oncotarget.com/abstract/7142), licensed under a CC-BY license.](http://images.novusbio.com/fullsize/Peroxiredoxin-4-Antibody-Western-Blot-NBP2-19778-img0004.jpg "<b>Biological Strategies Validation. </b>Western Blot: Peroxiredoxin 4 Antibody [NBP2-19778] - PRDX2 knockdown increases PRDX4 protein levels in HeLa cellsHeLa subclones were exposed to 20% or 1% O2 for indicated time. Each WCL was subject to immunoblot assays with the indicated antibodies. Image collected and cropped by CiteAb from the following publication (oncotarget.com/abstract/7142), licensed under a CC-BY license.")
![<b>Biological Strategies Validation. </b>Immunohistochemistry-Paraffin: Peroxiredoxin-4 Antibody [NBP2-19778] - Immunohistochemical analysis of paraffin-embedded MCF7 xenograft, using antibody at 1:250 dilution.](http://images.novusbio.com/fullsize/Peroxiredoxin-4-Antibody-Immunohistochemistry-Paraffin-NBP2-19778-img0003.jpg)
![Western Blot: Peroxiredoxin-4 Antibody [NBP2-19778] - Sample (30 ug of whole cell lysate) A: NT2D1 12% SDS PAGE gel, diluted at 1:1000.](http://images.novusbio.com/fullsize/Peroxiredoxin-4-Antibody-Western-Blot-NBP2-19778-img0001.jpg)
![Western Blot: Peroxiredoxin-4 Antibody [NBP2-19778] - Sample (50 ug of whole cell lysate) A: Mouse Brain, 12% SDS PAGE gel, diluted at 1:1000.](http://images.novusbio.com/fullsize/Peroxiredoxin-4-Antibody-Western-Blot-NBP2-19778-img0002.jpg)
![Western Blot: Peroxiredoxin 4 Antibody [NBP2-19778] - Expression of PRDX2 or PRDX4 does not affect HIF-1 alpha or HIF-2 alpha protein levelsA. & B. HeLa cells were transfected with EV or vector encoding PRDX2-V5 (A, P2) or PRDX4-V5 (B, P4), & exposed to 20% or 1% O2 for 24 h. WCL was subject to immunoblot assays with antibody against HIF-1 alpha , HIF-2 alpha , V5, or acin. C. HeLa-shSC (sc) & HeLa-shPRDX(2+4) (2+4) cells were exposed to 20% or 1% O2 for 24 h in the presence of doxycycline. WCL was subject to immunoblot assays with antibodies against HIF-1 alpha , HIF-2 alpha , PRDX2, PRDX4, & actin. Image collected & cropped by CiteAb from the following publication (//www.oncotarget.com/lookup/doi/10.18632/oncotarget.7142), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp2-19778_rabbit-polyclonal-peroxiredoxin-4-antibody-310202415334941.jpg)
![Western Blot: Peroxiredoxin 1 Antibody [NBP1-30973] - Various whole cell extracts (30 ug) were separated by 12% SDS-PAGE, and the membrane was blotted with PRX I antibody [N1C2] diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody (NBP2-19301) was used to detect the primary antibody.](http://images.novusbio.com/fullsize/Peroxiredoxin-1-Antibody-Western-Blot-NBP1-30973-img0014.jpg "Western Blot: Peroxiredoxin 1 Antibody [NBP1-30973] - Various whole cell extracts (30 ug) were separated by 12% SDS-PAGE, and the membrane was blotted with PRX I antibody [N1C2] diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody (NBP2-19301) was used to detect the primary antibody.")
![Immunocytochemistry/Immunofluorescence: Peroxiredoxin 1 Antibody [NBP1-30973] - HeLa cells were fixed in ice-cold MeOH for 5 min. Green: PRX I stained by PRX I antibody [N1C2] diluted at 1:500. Red: alpha Tubulin, a cytoskeleton marker, stained by alpha Tubulin antibody [GT114] diluted at 1:1000.Blue: Fluoroshield with DAPI.](http://images.novusbio.com/fullsize/Peroxiredoxin-1-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-30973-img0010.jpg)
![Immunohistochemistry-Paraffin: Peroxiredoxin 1 Antibody [NBP1-30973] - Mouse lung. PRX I antibody [N1C2] dilution: 1:500. Antigen Retrieval: Trilogy™ (EDTA based, pH 8.0) buffer, 15min](http://images.novusbio.com/fullsize/Peroxiredoxin-1-Antibody-Immunohistochemistry-Paraffin-NBP1-30973-img0009.jpg)
![Western Blot: Peroxiredoxin 1 Antibody [NBP1-30973] - Sample (30 ug of whole cell lysate) A:NIH-3T3 12% SDS PAGE; antibody diluted at 1:1000.](http://images.novusbio.com/fullsize/Peroxiredoxin-1-Antibody-Western-Blot-NBP1-30973-img0006.jpg)
![Western Blot: Peroxiredoxin 1 Antibody [NBP1-30973] - Sample (30 ug of whole cell lysate) A: 293T 12% SDS PAGE; antibody diluted at 1:1000.](http://images.novusbio.com/fullsize/Peroxiredoxin-1-Antibody-Western-Blot-NBP1-30973-img0007.jpg)
![Western Blot: Peroxiredoxin 1 Antibody [NBP1-30973] - Various whole cell extracts (30 ug) were separated by 12% SDS-PAGE, and the membrane was blotted with PRX I antibody [N1C2] diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody (NBP2-19301) was used to detect the primary antibody.](http://images.novusbio.com/fullsize/Peroxiredoxin-1-Antibody-Western-Blot-NBP1-30973-img0012.jpg)